🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gottfried E. Konecny

University of California, Los Angeles

ORCID: 0000-0001-6083-657X

Also affiliated with UCLA Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.6Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes

G3 Genes|Genomes|Genetics(2016)10.1534/g3.116.033514
Top 15%
1.4DataRank
Top 15%50 citations

James Rudd, Chen Wang, Habib Hamidi, Brooke L. Fridley, Gottfried E. Konecny +4 more

Papers

Driven by 14 papers — median percentile 60. Top paper: “Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)”.

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103
N/A
1.8DataRank · unranked
76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes

G3 Genes|Genomes|Genetics(2016)10.1534/g3.116.033514
Top 15%
1.4DataRank
Top 15%50 citations

James Rudd, Chen Wang, Habib Hamidi, Brooke L. Fridley, Gottfried E. Konecny +4 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019
N/A
0.718DataRank · unranked
119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102028
N/A
0.301DataRank · unranked
6 citations

Tara M. Davidson, Coriolan Lebreton, Leah A. Marsh, Deandra K. Chetram, Hunter J. Atkinson +14 more

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.006
Top 65%
0.208DataRank
Top 65%3 citations

Angeles Alvarez Secord, Steven G. Friedman, Erinn M. Hade, Carson Smitherman, Nikita Bisht +14 more

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-1286
N/A
0DataRank · unranked
8 citations

Rachel Abbotts, Kaushlendra Tripathi, Collin M. Coon, Saranya Rajendran, Elnaz Abbasi Farid +26 more

78MO Mirvetuximab soravtansine exposure is associated with an increased incidence of cataract surgery in patients with ovarian cancer

ESMO Open(2025)10.1016/j.esmoop.2025.105207
N/A
0DataRank · unranked
0 citations

Alexandra Smick, Oladunni Alomaja, Bridget Johnson, Chiu-Chen Tseng, Ritu Salani +3 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919
N/A
0DataRank · unranked
0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094
N/A
0DataRank · unranked
0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1
N/A
0DataRank · unranked
0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more

PAX8 orchestrates an angiogenic program through interaction with SOX17

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.09.290387
N/A
0DataRank · unranked
9 citations

Marilyn A. Mitchell, Cristina Arruza, Priyanka Rawat, Simone Sidoli, Robbin Nameki +11 more

State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report

JCO Precision Oncology(2022)10.1200/po.22.00355
N/A
0DataRank · unranked
8 citations

Katherine C. Fuh, Rebecca C. Arend, Gottfried E. Konecny, Panagiotis A. Konstantinopoulos, Kunle Odunsi +4 more

Data from Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma

(2023)10.1158/1078-0432.c.6518930.v1
N/A
0DataRank · unranked
0 citations

Gottfried E. Konecny, Mirela Fekete, Kuang-Yui Michael Chen, Amer Karam, David J. Mulholland +5 more

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0393
N/A
0DataRank · unranked
55 citations

Akshaya V. Annapragada, Pien Lof, Sarah Short, Adrianna L. Bartolomucci, Dimitrios Mathios +30 more